Molecular Brain Imaging and the Neurobiology and Genetics of Schizophrenia

It has been hypothesized that schizophrenia is related to dysfunction in temporolimbic-prefrontal neuronal networks, which is acquired early in an individual’s development. After puberty, relatively reduced prefrontal control of striatal dopaminergic neurotransmission may lead to unmodulated striatal dopamine (DA) activity, and the positive symptoms of acute psychosis. Brain imaging studies support the notion of prefrontal dysfunction in schizophrenia and correlated upregulation of presynaptic striatal DA activity. Recent molecular brain imaging studies have combined genetic assessments with a multimodal neuroimaging approach to further refine our understanding of the pathophysiologic architecture of the disorder. We review the literature on functional brain imaging in schizophrenia and discuss genotype effects on core psychotic symptoms. A promising research strategy is the identification of genetic and environmental factors that contribute to intermediate phenotypes such as working memory deficits in schizophrenia. Molecular brain imaging can help to unravel the complex interactions between genes and environment and its association with neuronal network dysfunction in schizophrenia.

Dopamine - PET - SPECT - fMRI - COMT genotype - neurodevelopment

References

• 1 Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles L S, Weiss R. et al . From the cover: increased baseline occupancy of D2 receptors by dopamine in schizophrenia.  Proc Natl Acad Sci U S A. 2000;  97 8104-8109
• 2 Akil M, Kolachana B, Rothmond D A, Hyde T M, Weinberger D R, Kleinman J E. Catechol-O-Methyltransferase genotype and dopamine regulation in human brain.  J Neurosci. 2003;  23 2008-2013
• 3 Bertolino A, Knable M B, Saunders R C, Callicott J H, Kolachana B, Mattay V S, Bachevalier J, Frank J A, Egan M, Weinberger D R. The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia.  Biol Psychiatry. 1999;  45 660-667
• 4 Bleuler E. Dementia praecox oder die Gruppe der Schizophrenien. Springer Berlin; 1911
• 5 Blackwood D H, Glabus M F, Dunan J, O’Carroll R E, Muir W J, Ebmeier K P. Altered cerebral perfusion measured by SPECT in relatives of patients with schizophrenia. Correlations with memory and P300.  Br J Psychiatry. 1999;  175 357-366
• 6 Breier A, Su T P, Saunders R, Carson R E, Kolachana B S, de Bartolomeis A, Weinberger D R, Weisenfeld N, Malhotra A K, Eckelman W C, Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.  Proc Natl Acad Sci U S A. 1997;  94 2569-74
• 7 Callicott J H, Mattay V S, Bertolino A, Finn K, Coppola R, Frank J A, Goldberg T E, Weinberger D R. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI.  Cereb Cortex. 1999;  9 20-26
• 8 Callicott J H, Bertolino A, Mattay V S, Langheim F J, Duyn J, Coppola R, Goldberg T E, Weinberger D R. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited.  Cereb Cortex. 2000;  10 1078-92
• 9 Daniel D G, Weinberger D R, Jones D W, Zigun J R, Coppola R, Handel S, Bigelow L B, Goldberg T E, Berman K F, Kleinman J E. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia.  J Neurosci. 1991;  11 1907-1917
• 10 Dao-Castellana M H, Paillere-Martinot M L, Hantraye P, Attar-Levy D, Remy P, Crouzel C, Artiges E, Feline A, Syrota A, Martinot J L. Presynaptic dopaminergic function in the striatum of schizophrenic patients.  Schizophr Res. 1997;  23 167-174
• 11 Donchin E, Coles M GH. Is the P300 component a manifestation of context updating?.  Behavioral Brain Science. 1988;  11 357-374
• 12 Egan M F, Goldberg T E, Kolachana B S, Callicott J H, Mazzanti C M, Straub R E, Goldman D, Weinberger D R. Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia.  Proc Natl Acad Sci U S A. 2001;  98 6917-6922
• 13 Ford J M, Mathalon D H, Whitfield S, Faustman W O, Roth W T. Reduced communication between frontal and temporal lobes during talking in schizophrenia.  Biol Psychiatry. 2002;  51 485-492
• 14 Gallinat J, Riedel M, Juckel G, Sokullu S, Frodl T, Moukhtieva R. et al . P300 and symptom improvement in schizophrenia.  Psychopharmacology (Berl). 2001;  158 55-65
• 15 Gallinat J, Mulert C, Bajbouj M, Herrmann W M, Schunter J, Senkowski D. et al . Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia.  Neuroimage. 2002;  17 110-127
• 16 Gallinat J, Sander T, Bajbouj M, Schlattmann P, Xu K, Ferro E F. et al . Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing.  Biol Psychiatry. 2003;  54 40-48
• 17 Gilbertson M W, van Kammen D P. Recent and remote memory dissociation: medication effects and hippocampal function in schizophrenia.  Biol Psychiatry. 1997;  42 585-595
• 18 Goldberg T E, Weinberger D R. Effects of neuroleptic medications on the cognition of patients with schizophrenia: a review of recent studies.  J Clin Psychiatry. 1996;  57 Suppl. 9 62-65
• 19 Heckers S, Rauch S L, Goff D, Savage C R, Schacter D L, Fischman A J, Alpert N M. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia.  Nat Neurosci. 1998;  1 318-323
• 20 Hegerl U, Juckel G, Müller-Schubert A, Pietzcker A, Gaebel W. Schizophrenics with small P300: a subgroup with a neurodevelopmental disturbance and a high risk for tardive dyskinesia?.  Acta Psychiatr Scand. 1995;  91 120-125
• 21 Heinz A, Knable M B, Coppola R, Gorey J G, Jones D W, Lee K S, Weinberger D R. Psychomotor slowing, negative symptoms and dopamine receptor availability IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients.  Schizophr Res. 1998;  31 19-26
• 22 Heinz A, Saunders R C, Kolachana B S, Jones D W, Gorey J G, Bachevalier J, Weinberger D R. Striatal dopamine receptors and transporters in monkeys with neonatal temporal limbic damage.  Synapse. 1999;  32 71-79
• 23 Heinz A, Weinberger D R. Schizophrenia: The neurodevelopmental hypothesis. Current concepts in psychiatry. (Psychiatrie der Gegenwart). Springer Berlin; 2000: p. 89-104
• 24 Heinz A. Dopaminergic dysfunction in alcoholism and schizophrenia/psychopathological and behavioral correlates.  Eur Psychiatry. 2002;  17 9-16
• 25 Heinz A, Romero B, Weinberger D R. Functional mapping with Single Photon Emission Computed Tomography (and Positron Emission Tomography). In: Lawrie, Johnstone, Weinberger, editors Brain Imaging in Schizophrenia. Part II - Functional Neuroimaging/Chapter 8. Oxford University Publications 2003a (in press)
• 26 Hietala J, Syvalahti E, Vilkman H, Vuorio K, Rakkolainen V, Bergman J, Haaparanta M, Solin O, Kuoppamaki M, Eronen E, Ruotsalainen U, Salokangas R K. Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.  Schizophr Res. 1999;  35 41-50
• 27 Hirsh S R, Weinberger D R. Schizophrenia. Blackwell Science Ltd. 2^nd Rev. 2003
• 28 Jackson J H. Die Croon-Vorlesungen über Aufbau und Abbau des Nervensystems. Berlin; 1927
• 29 Juckel G, Mendlin A, Jacobs B L. Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and transcranial magnetic stimulation in depression.  Neuropsychopharmacology. 1999;  21 391-398
• 30 Juckel G, Müller-Schubert A, Gaebel W, Hegerl U. Residual symptoms and P300 in schizophrenic outpatients.  Psychiatry Res. 1996;  65 23-32
• 31 Juckel G, Reischies F M, Müller-Schubert A, Vogel A C, Gaebel W, Hegerl U. Ventricle size and P300 in schizophrenia.  Eur Arch Psychiatry Clin Neurosci. 1994;  243 352-354
• 32 Kegeles L S, Abi-Dargham A, Zea-Ponce Y, Rodenhiser-Hill J, Mann J J, Van Heertum R L, Cooper T B, Carlsson A, Laruelle M. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.  Biol Psychiatry. 2000;  48 627-640
• 33 Kotrla K J, Weinberger D R. Brain imaging in schizophrenia.  Annu Rev Med. 1995;  46 113-122
• 34 Laruelle M, Innis R B. Images in neuroscience. SPECT imaging of synaptic dopamine.  Am J Psychiatry. 1996b;  153 1249
• 35 Laruelle M, Iyer R N, al-Tikriti M S, Zea-Ponce Y, Malison R, Zoghbi S S, Baldwin R M, Kung H F, Charney D S, Hoffer P B, Innis R B, Bradberry C W. Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates.  Synapse. 1997;  25 1-14
• 36 Manoach D S, Gollub R L, Benson E S, Searl M M, Goff D C, Halpern E, Saper C B, Rauch S L. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance.  Biol Psychiatry. 2000;  48 99-109
• 37 Marenco S, Weinberger D R. The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave.  Dev Psychopathol. 2000;  12 501-527
• 38 Mattay V S, Berman K F, Ostrem J L, Esposito G, Van Horn J D, Bigelow L B, Weinberger D R. Dextroamphetamine enhances ”neural network-specific” physiological signals: a positron-emission tomography rCBF study.  J Neurosci. 1996;  16 4816-4822
• 39 Mattay V S, Goldberg T E, Fera F, Hariri A R, Tessitore A, Egan M F, Kolachana B, Callicott J H, Weinberger D R. Catechol O-methyltransferase val¹⁵⁸-met genotype and individual variation in the brain response to amphetamine.  PNAS. 2003;  100 6168-6191
• 40 McCarley R W, Salisbury D F, Hirayasu Y, Yurgelun-Todd D A, Tohen M, Zarate C. et al . Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia.  Arch Gen Psychiatry. 2002;  59 321-331
• 41 Meyer-Lindenberg A, Miletich R S, Kohn P D, Esposito G, Carson R E, Quarantelli M, Weinberger D R, Berman K F. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.  Nat Neurosci. 2002;  5 267-271
• 42 Molnar M. On the origin of the P3 event-related potential component.  Int J Psychophysiology. 1994;  17 129-144
• 43 Norman R M, Malla A K, Williamson P C, Morrison-Stewart S L, Helmes E, Cortese L. EEG coherence and syndromes in schizophrenia.  Br J Psychiatry. 1997;  170 411-415
• 44 Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, Someya Y, Sassa T, Sudo Y, Matsushima E, Iyo M, Tateno Y, Toru M. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.  Nature. 1997;  385 634-646
• 45 Reith J, Benkelfat C, Sherwin A, Yasuhara Y, Kuwabara H, Andermann F, Bachneff S, Cumming P, Diksic M, Cyve S E. et al . Elevated dopa decarboxylase activity in living brain of patients with psychosis.  Proc Natl Acad Sci U S A. 1994;  91 11 651-11 654
• 46 Robinson T E, Berridge K C. The neural basis of drug craving: an incentive-sensitization theory of addiction.  Brain Res Brain Res Rev. 1993;  18 247-291
• 47 Saunders R C, Kolachana B S, Bachevalier J, Weinberger D R. Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine.  Nautre. 1998;  393 169-171
• 48 Schacter D L, Alpert N M, Savage C R, Rauch S L, Albert M S. Conscious recollection and the human hippocampal formation: evidence from positron emission tomography.  Proc Natl Acad Sci U S A. 1996;  93 321-325
• 49 Schmidt K, Nolte-Zenker B, Patzer J, Bauer M, Schmidt L G, Heinz A. Psychopathological correlates of reduced dopamine receptor sensitivity in depression schizophrenia, and opiate and alcohol dependence.  Pharmacopsychiatry. 2001;  34 66-72
• 50 Schultz W, Apicella P, Ljungberg T. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task.  J Neurose. 1993;  13 900-913
• 51 Weinberger D R. Implications of normal brain development for the pathogenesis of schizophrenia.  Arch Gen Psychiatry. 1987;  44 660-669
• 52 Weinberger D R. Bergman KF, Illowsky BP. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.  Arch Gen Psychiatry. 1988;  45 605-615
• 53 Weinberger D R, Berman K F, Suddath R, Torrey E F. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins.  Am J Psychiatry. 1992;  149 890-897
• 54 Weinberger D R, Lipska B K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground.  Schizophr Res. 1995;  16 87-110
• 55 Weinberger D R, Egan M F, Bertolino A, Callicot J H, Mattay V S, Lipska B K, Berman K F, Goldberg T E. Prefrontal neurons and the genetics of schizophrenia.  Biol Psychiatry. 2001;  50 825-844